What is Axiom (Biotechnology) worth?
$121.0Mlast known valuation
Free account
See the evidence behind this price
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Axiom (Biotechnology)
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for Axiom (Biotechnology) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How Axiom (Biotechnology)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Axiom (Biotechnology), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Axiom (Biotechnology) worth?
- Axiom (Biotechnology)'s last known valuation is $121.0M.
- How much has Axiom (Biotechnology) raised?
- Axiom (Biotechnology) has raised $30.0M in total funding across its recorded rounds.